NCT06835634

Brief Summary

Neurosurgical diseases encompass a highly heterogeneous group of conditions, including oncological, malformative, traumatic, spinal, vascular, infectious diseases, and cerebrospinal fluid dynamics disorders. Several systematic reviews on the level of evidence in neurosurgical diseases have documented the low percentage of high-quality scientific evidence in this field of medicine. Clinical practice is strongly influenced by individual physician preferences, leading to significant heterogeneity among different centers both in Italy and internationally. This overall picture highlights the need for tools that can accurately characterize the numerous diagnostic variables influencing therapeutic outcomes in patients with neurosurgical diseases. Primary Objective To establish a prospective data collection of adult patients with neurosurgical diseases, providing real-life data on the current management of patients at the Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome and the participating centers. Secondary Objectives To create a database of adult patients with neurosurgical diseases who may be potential candidates for enrollment in clinical trials. To conduct observational research on neurosurgical diseases, particularly in cases where no curative treatment options are currently available. To identify potential predictors of poor outcomes or treatment response. To assess the clinical history and treatment response of patients, including for internal audit purposes (e.g., supporting Morbidity \& Mortality conferences). To provide support for the development and monitoring of quality indicators related to patient care.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7,500

participants targeted

Target at P75+ for all trials

Timeline
117mo left

Started Jan 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Jan 2025Dec 2035

Study Start

First participant enrolled

January 15, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 14, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 19, 2025

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2035

Expected
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2035

Last Updated

February 19, 2025

Status Verified

February 1, 2025

Enrollment Period

10.1 years

First QC Date

February 14, 2025

Last Update Submit

February 14, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Data collection of adult patients with neurosurgical diseases

    To establish a prospective data collection of adult patients with neurosurgical diseases, providing real-life data on the current management of patients at the Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome and the participating centers.

    1 year

Secondary Outcomes (4)

  • database of adult patients with neurosurgical diseases

    1 year

  • observational research on neurosurgical diseases

    1 year

  • potential predictors of treatment response

    1 year

  • development and monitoring of quality indicators

    1 year

Interventions

PROMs and psychological tests submission in patients affected by neurosurgical diseases

Also known as: psychological tests

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Population affected by a \*\*neurosurgical disease\*\* at the time of \*\*first contact with the patient\*\*, whether in an \*\*outpatient or inpatient setting\*\*, at the facilities of the centers participating in the study.

You may qualify if:

  • Age at first contact equal to or greater than 18 years at the time of informed consent signature.
  • Diagnosis of a neurosurgical disease.

You may not qualify if:

  • Refusal to provide written informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, UOC Neurochirurgia

Roma, 00168, Italy

Location

MeSH Terms

Conditions

Spinal DiseasesCentral Nervous System DiseasesPeripheral Nervous System Diseases

Interventions

Psychological Tests

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal DiseasesNervous System DiseasesNeuromuscular Diseases

Intervention Hierarchy (Ancestors)

Behavioral Disciplines and Activities

Study Officials

  • Alessandro Olivi, MD

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 14, 2025

First Posted

February 19, 2025

Study Start

January 15, 2025

Primary Completion (Estimated)

February 10, 2035

Study Completion (Estimated)

December 31, 2035

Last Updated

February 19, 2025

Record last verified: 2025-02

Locations